Skip to content

Risk Factors for Neuroendocrine Neoplasms

Risk Factors for Neuroendocrine Neoplasms: a Case-control Study Based on a Record Linkage of Registry and Claims Data

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06282016
Enrollment
14250
Registered
2024-02-28
Start date
2025-05-15
Completion date
2026-08-31
Last updated
2026-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuroendocrine Neoplasm of Gastrointestinal Tract (Disorder), Neuroendocrine Neoplasm of Lung

Keywords

Neuroendocrine neoplasms, Colorectal cancer, Risk factors, Case-Control Study, Cancer Registry

Brief summary

Recent studies show an increase in neuroendocrine neoplasms, especially for the digestive tract. Previous studies suggest various risk factors that were observed for various tumor sites, e.g. a family history of cancer, tobacco and alcohol consumption as well as metabolic disorders including diabetes and obesity. A risk factor that has been little studied to date is depressive disorders, which could increase the risk of neuroendocrine neoplasms either independently or through associated risk behaviors and/or antidepressant medication. The aim of this study is to identify risk factors for neuroendocrine neoplasms based on a case-control study in order to better understand the increase of neuroendocrine neoplasms in recent decades. The study is based on a record linkage of data from the Bavarian Cancer Registry and data from the Bavarian Association of Statutory Health Insurance Accredited Physicians. While the data from the Bavarian Cancer Registry enables the identification of neuroendocrine neoplasms on the basis of histopathological findings and thus is the basis for selecting cases, the claims data from the Bavarian Association of Statutory Health Insurance Accredited Physicians provides the source population as well data on diagnoses and thus enables the investigation of risk factors.

Interventions

OTHERCase-control study (no intervention)

Observation of risk factors in cases and controls

Sponsors

Bavarian Association of Statutory Health Insurance Accredited Physicians
CollaboratorUNKNOWN
Bavarian Cancer Registry
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Persons with a statutory health insurance (about 85% of the population) and at least one outpatient physician contact in Bavaria between 2021 and 2023 * Residence in Bavaria

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Assured NEN diagnosis of the BPS2021-2023Neuroendocrine neoplasm of the bronchopulmonary system
Assured NEN diagnosis of the GEPS2021-2023Neuroendocrine neoplasm of the gastroenteropancreatic system

Secondary

MeasureTime frameDescription
Assured NET diagnosis of the BPS2021-2023Neuroendocrine tumour of the bronchopulmonary system
Assured NEC diagnosis of the BPS2021-2023Neuroendocrine carcinoma of the bronchopulmonary system
Assured NET diagnosis of the GEPS2021-2023Neuroendocrine tumour of the gastroenteropancreatic system
Assured NEC diagnosis of the GEPS2021-2023Neuroendocrine carcinoma of the gastroenteropancreatic system

Countries

Germany

Contacts

Primary ContactSven Voigtländer
sven.voigtlaender@lgl.bayern.de+49-(0)9131-6808
Backup ContactJacqueline Müller-Nordhorn
jacqueline.mueller-nordhorn@lgl.bayern.de+49-(0)9131-6808

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026